https://www.strategyadd.com https://www.strategyadd.com/about https://www.strategyadd.com/contact-us https://www.strategyadd.com/credentials https://www.strategyadd.com/deal-flow https://www.strategyadd.com/engagements https://www.strategyadd.com/insights https://www.strategyadd.com/m-a-due-diligence https://www.strategyadd.com/privacy-policy https://www.strategyadd.com/terms-and-conditions https://www.strategyadd.com/insights/strategy-advises-aci-worldwide-nasdaq-aciw-on-divestiture-to-one-equity-partners https://www.strategyadd.com/insights/strategy-advises-aon-plc-nyse-aon-on-divestiture-to-alight-nyse-alit-2 https://www.strategyadd.com/insights/strategy-advises-aon-plc-nyse-aon-on-divestiture-to-chubb-limited-nyse-cb https://www.strategyadd.com/insights/strategy-advises-aon-plc-nyse-aon-on-divestiture-to-tcdi-2 https://www.strategyadd.com/insights/strategy-advises-aon-plc-nyse-aon-on-divestiture-to-the-riverside-company https://www.strategyadd.com/insights/strategy-advises-cd-r-on-acquisition-of-truist-insurance-holdings https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-acquisition-of-anacor-pharma-nasdaq-anac https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-acquisition-of-array-biopharma-nasdaq-arry https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-acquisition-of-hospira-inc-nyse-hsp https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-acquisition-of-medivation-inc-nasdaq-mdvn https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-acquisition-of-therachon https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-divestiture-to-icu-medical-nasdaq-icui https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-joint-venture-with-glaxosmithkline-plc-nyse-gsk https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-merger-of-upjohn-and-mylan-nasdaq-myl-into-viatris-nasdaq-vtrs https://www.strategyadd.com/insights/strategy-advises-pfizer-nyse-pfe-on-merger-with-allergan-nyse-agn https://www.strategyadd.com/insights/strategy-advises-securian-on-divestiture-to-cetera-financial-group-2 https://www.strategyadd.com/insights/strategy-advises-securian-on-divestiture-to-standard-insurance-company https://www.strategyadd.com/insights/strategy-advises-transunion-nyse-tru-on-acquisition-of-verisk-financial-services-nasdaq-vrsk https://www.strategyadd.com/insights/warren-buffet-invests-6-7-billion-in-strategy-advised-deal